In summary, Bcl-xL and Bcl2 are key mediators of apoptosis [48] and may represent promising therapeutic targets for colorectal cancer (CRC) treatment, as demonstrated by our experimental results. This evidence concerns the gene BCL2 and colorectal carcinoma.